Lower subjective quality of life and the development of social anxiety symptoms after the discharge of elderly patients with remitted schizophrenia: A 5-year longitudinal study

Comprehensive Psychiatry

Volumn 53, Issue 7, 2012, Pages 946-951

  Kumazaki, Hirokazu ^a   Kobayashi, Hiroyuki ^a,b   Niimura, Hidehito ^a,c   Kobayashi, Yasushi ^a   Ito, Shinya ^d   Nemoto, Takahiro ^d   Sakuma, Kei ^c   Kashima, Haruo ^a   Mizuno, Masafumi ^d  

^a KEIO UNIVERSITY   (Japan)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Asaka Hospital   (Japan)

^d TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOBAL ASSESSMENT OF FUNCTIONING SCALE; HUMAN; LIEBOWITZ SOCIAL ANXIETY SCALE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SOCIAL FUNCTIONING SCALE; SOCIAL INTERACTION; SOCIAL PHOBIA; TREATMENT DURATION;

AGED; ANTIPSYCHOTIC AGENTS; ANXIETY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT DISCHARGE; PHOBIC DISORDERS; PROSPECTIVE STUDIES; QUALITY OF LIFE; REMISSION INDUCTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT;

EID: 84866518364     PISSN: 0010440X     EISSN: 15328384     Source Type: Journal    
DOI: 10.1016/j.comppsych.2012.03.002     Document Type: Article

References (23)

1. J.M. Kane Treatment strategies to prevent relapse and encourage remission J Clin Psychiatry 68 2007 27 30
2. R.J. Braga, G. Petrides, and I. Figueira Anxiety disorders in schizophrenia Compr Psychiatry 45 6 2004 460 468
3. J.D. Huppert, and T.E. Smith Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms CNS Spectr 10 9 2005 721 731
4. S. Pallanti, L. Quercioli, and E. Hollander Social anxiety in outpatients with schizophrenia: a relevant cause of disability Am J Psychiatry 161 2004 53 58
5. M. Mizuno, K. Sakuma, Y. Ryu, S. Munakata, T. Takebayashi, and M. Murakami The Sasagawa Project: a model for deinstitutionalization in Japan Keio J Med 54 2005 95 101
6. Y. Ryu, M. Mizuno, K. Sakuma, S. Munakata, T. Takebayashi, and M. Murakami Deinstitutionalization of long-stay patients with schizophrenia: the 2-year social and clinical outcome of a comprehensive intervention program in Japan Aust N Z J Psychiatry 40 2006 462 470
7. R.J. Braga, M.V. Mendlowicz, R.P. Marrocos, and I.L. Figueira Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life J Psychiatr Res 39 4 2005 409 414
8. J.L. Wetherell, B.W. Palmer, S.R. Thorp, T.L. Patterson, S. Golshan, and D.V. Jeste Anxiety symptoms and quality of life in middle-aged and older outpatients with schizophrenia and schizoaffective disorder J Clin Psychiatry 64 2003 1476 1482
9. P.H. Lysaker, and J. Hammersley Association of delusions and lack of cognitive flexibility with social anxiety in schizophrenia spectrum disorders Schizophr Res 86 2006 147 153
10. I.R.H. Falloon, I. Montero, M. Sungur, A. Mastroeni, U. Malm, and M. Economou Implementation of evidence-based treatment for schizophrenic disorders: two-year outcome of an international field trial of optimal treatment World Psychiatry 3 2 2004 104 109
11. M.R. Liebowitz Social phobia Mod Probl Pharmacopsychiatry 22 1987 141 173
12. J.C. Ballenger Treatment of anxiety disorders to remission J Clin Psychiatry 62 suppl 12 2001 5 9
13. D.S. Mennin, D.M. Fresco, R.G. Heimberg, F.R. Schneier, S.O. Davies, and M.R. Liebowitz Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale J Anxiety Disord 16 2002 661 673
14. A. Hofer, S. Baumgartner, T. Bodner, M. Edlinger, M. Hummer, and G. Kemmler Patient outcomes in schizophrenia II: the impact of cognition Eur Psychiatry 20 5-6 2005 395 402
15. K. Hayman-White, and B. Happell Critique of Falloon and the Optimal Treatment Project Int J Ment Health Nurs 16 2007 44 49
16. K.M. Griffiths, Y. Nakane, H. Christensen, K. Yoshioka, A.F. Jorm, and H. Nakane Stigma in response to mental disorders: a comparison of Australia and Japan BMC Psychiatry 23 2006 6 21
17. S. Pallanti, L. Quercioli, A. Rossi, and A. Pazzagli The Emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation J Clin Psychiatry 60 1999 819 823
18. 2 receptor binding potential in social phobia Am J Psychiatry 157 2000 457 459
19. J. Tiihonen, J. Kuikka, K. Bergström, U. Lepola, H. Koponen, and E. Leinonen Dopamine reuptake site densities in patients with social phobia Am J Psychiatry 154 1997 239 242
20. S.J. Cosoff, and J. Hafner The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder Aust N Z J Psychiatry 32 1998 67 72
21. N.C. Andreasen, W.T. Carpenter, J.M. Kane, R.A. Lasser, S.R. Marder, and D.R. Weinberger Remission in schizophrenia: proposed criteria and rationale for consensus Am J Psychiatry 162 2005 441 449
22. P.D. Harvey, and A.S. Bellack Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept? Schizophr Bull 35 2 2009 300 306
23. C. Li, and Y. He Morita therapy for schizophrenia Schizophr Bull 34 6 2008 1021 1023